Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hellenbrand

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The American Journal of Nursing|July 1, 1981
An eclectic approach to practiceJ F Miller, D Hellenbrand
Diabetes Research and Clinical Practice|May 1, 1991
Low prevalence of microalbuminuria in normotensive patients with insulin-dependent diabetes mellitusL Ramirez, J Rosenstock, C Arauz, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The prognostic value of the soluble urokinase-type plasminogen activator receptor (s-uPAR) in plasma of breast cancer patients with and without metastatic diseaseM R Nijziel, R Van Oerle, D Hellenbrand, et al.
Thrombosis Research|July 18, 2025
tPA-ROTEM identifies hyperfibrinolytic profile in a significant proportion of patients with bleeding disorder of unknown cause (BDUC)A L L Monard, D Hellenbrand, P Verhezen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The American Journal of Nursing|July 1, 1981
An eclectic approach to practiceJ F Miller, D Hellenbrand
Diabetes Research and Clinical Practice|May 1, 1991
Low prevalence of microalbuminuria in normotensive patients with insulin-dependent diabetes mellitusL Ramirez, J Rosenstock, C Arauz, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The prognostic value of the soluble urokinase-type plasminogen activator receptor (s-uPAR) in plasma of breast cancer patients with and without metastatic diseaseM R Nijziel, R Van Oerle, D Hellenbrand, et al.
Thrombosis Research|July 18, 2025
tPA-ROTEM identifies hyperfibrinolytic profile in a significant proportion of patients with bleeding disorder of unknown cause (BDUC)A L L Monard, D Hellenbrand, P Verhezen, et al.
Pageof 1